- Home
- NBN vs TECX Comparison
NBN vs TECX Comparison
Compare NBN & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBN
- TECX
- Stock Information
- Founded
- NBN 1872
- TECX 2019
- Country
- NBN United States
- TECX United States
- Employees
- NBN N/A
- TECX N/A
- Industry
- NBN Major Banks
- TECX
- Sector
- NBN Finance
- TECX
- Exchange
- NBN Nasdaq
- TECX Nasdaq
- Market Cap
- NBN 753.2M
- TECX 647.7M
- IPO Year
- NBN N/A
- TECX 2018
- Fundamental
- Price
- NBN $91.78
- TECX $47.44
- Analyst Decision
- NBN Buy
- TECX Strong Buy
- Analyst Count
- NBN 2
- TECX 5
- Target Price
- NBN $91.00
- TECX $72.25
- AVG Volume (30 Days)
- NBN 66.2K
- TECX 93.8K
- Earning Date
- NBN 01-28-2025
- TECX 11-07-2024
- Dividend Yield
- NBN 0.04%
- TECX N/A
- EPS Growth
- NBN 12.22
- TECX N/A
- EPS
- NBN 7.69
- TECX N/A
- Revenue
- NBN $157,668,000.00
- TECX N/A
- Revenue This Year
- NBN N/A
- TECX N/A
- Revenue Next Year
- NBN $10.37
- TECX N/A
- P/E Ratio
- NBN $11.93
- TECX N/A
- Revenue Growth
- NBN 16.87
- TECX N/A
- 52 Week Low
- NBN $49.07
- TECX $1.40
- 52 Week High
- NBN $105.44
- TECX $53.34
- Technical
- Relative Strength Index (RSI)
- NBN 37.01
- TECX 53.77
- Support Level
- NBN $96.78
- TECX $42.83
- Resistance Level
- NBN $99.50
- TECX $48.85
- Average True Range (ATR)
- NBN 2.97
- TECX 3.42
- MACD
- NBN -1.35
- TECX -0.84
- Stochastic Oscillator
- NBN 7.13
- TECX 43.97
About NBN Northeast Bank
Northeast Bank provides banking and financial services to individual and corporate customers in the US. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived primarily from interest and dividends from the bank.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.